Dyne Therapeutics, Inc. (DYN)
16.74
+0.82
(+5.15%)
USD |
NASDAQ |
May 20, 09:45
Dyne Therapeutics Shareholders Equity (Quarterly) : 865.06M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Arrowhead Pharmaceuticals, Inc. | 613.98M |
| BioCryst Pharmaceuticals, Inc. | -553.84M |
| Biogen, Inc. | 18.65B |
| Insmed, Inc. | 704.85M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.080B |
| Total Liabilities (Quarterly) | 214.90M |
| Debt to Equity Ratio | 0.2022 |
| Current Ratio | 19.92 |
| Net Debt Paydown Yield | -1.01% |